AUG 14, 2026 · PHASE 2 TRIAL
A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast Cancer
ClinicalTrials.gov
Phase 2 bridging study in a population-specific cohort (Japanese patients) with a surrogate primary endpoint (PFS); results not yet reported in this registry record.
Reported
Planned enrollment70
PhasePhase 2
Primary outcome measureProgression-free Survival as Assessed by th…